| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MUS.880170213 |
| P698 | PubMed publication ID | 8114792 |
| P2093 | author name string | Eisen AA | |
| Prout AJ | |||
| P2860 | cites work | Cutaneous reflex responses and their central nervous pathways studied in man. | Q39361222 |
| The 'late' reflex responses to muscle stretch: the 'resonance hypothesis' versus the 'long-loop hypothesis'. | Q41624097 | ||
| Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle | Q48660962 | ||
| Silent period produced by unloading of muscle during voluntary contraction | Q53806676 | ||
| Stimulation of the human motor cortex through the scalp | Q37769276 | ||
| P433 | issue | 2 | |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 217-223 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Muscle and Nerve | Q15764281 |
| P1476 | title | The cortical silent period and amyotrophic lateral sclerosis | |
| P478 | volume | 17 |
| Q36479616 | ALS biomarkers for therapy development: State of the field and future directions |
| Q35489953 | Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS |
| Q71974081 | Abnormalities of cortical inhibitory neurons in amyotrophic lateral sclerosis |
| Q36940301 | Age-dependent changes in the neural correlates of force modulation: an fMRI study |
| Q46537643 | Age-related differences in corticospinal control during functional isometric contractions in left and right hands |
| Q73039577 | Alteration of motor cortex excitability in response to intermittent photic stimulation |
| Q34566679 | Amyotrophic lateral sclerosis: objective upper motor neuron markers |
| Q26747024 | Assessment of the upper motor neuron in amyotrophic lateral sclerosis |
| Q48257063 | Assessment of upper and lower motor neurons in Kennedy's disease: implications for corticomotoneuronal PSTH studies |
| Q35501852 | Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis |
| Q37514514 | Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis |
| Q38080951 | Cortical excitability and neurology: insights into the pathophysiology |
| Q41818176 | Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype |
| Q48881997 | Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis |
| Q73128596 | Cortical silent period in patients with amyotrophic lateral sclerosis |
| Q73404277 | Corticomotoneuronal activity in ALS: changes in the peristimulus time histogram over time |
| Q40832020 | Corticomotorneuronal hyper-excitability in amyotrophic lateral sclerosis |
| Q48330428 | Dependence of the transcranially induced silent period on the 'instruction set' and the individual reaction time |
| Q44205425 | Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis |
| Q48533641 | Different patterns of I-waves summation in ALS patients according to the central conduction time. |
| Q39939962 | Disorders of consciousness: further pathophysiological insights using motor cortex transcranial magnetic stimulation |
| Q34044159 | Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders |
| Q44191823 | Emergent Measure for Clinical Trials: TMS - con. |
| Q97066870 | Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology |
| Q60920729 | Functional Biomarkers for Amyotrophic Lateral Sclerosis |
| Q48191388 | Impaired interhemispheric inhibition in amyotrophic lateral sclerosis |
| Q48482385 | Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease |
| Q38653220 | Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities |
| Q40817864 | Interaction of the neuroprotective drug riluzole with GABA(A) and glycine receptor channels |
| Q34547625 | Magnetic stimulation of the central and peripheral nervous systems |
| Q33853033 | Magnetoelectric brain stimulation in the assessment of brain physiology and pathophysiology. |
| Q48239360 | Measuring the cortical silent period can increase diagnostic confidence for amyotrophic lateral sclerosis |
| Q44029869 | Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters |
| Q36203600 | Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials |
| Q92661380 | Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques |
| Q74363123 | Peripheral silent periods in essential tremor |
| Q43748714 | Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. |
| Q92206079 | Relative preservation of triceps over biceps strength in upper limb-onset ALS: the 'split elbow' |
| Q48387899 | Responses of masseter muscles to transcranial magnetic stimulation in patients with amyotrophic lateral sclerosis |
| Q48726185 | Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. |
| Q42369773 | Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement |
| Q53920861 | The effect of riluzole in amyotrophic lateral sclerosis: a study with cortical stimulation. |
| Q67215849 | Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability. |
| Q37206683 | Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights |
| Q43860553 | Transcranial magnetic stimulation of motor pathways directed to muscles supplied by cranial nerves in amyotrophic lateral sclerosis |
| Q48460914 | Transcranial magnetic stimulation: summary |
| Q97570189 | Use of transcranial magnetic stimulation in the treatment of selected movement disorders |
| Q60054023 | Utility of threshold tracking transcranial magnetic stimulation in ALS |
| Q71922824 | [Alterations of various parameters of evoked motor potentials in amyotrophic lateral sclerosis] |
Search more.